Inemet presentations

Presentations
Documents
Infographics

Latest Most Popular

EUFEPS and European Initiatives in Pharmaceutical Sciences

16 years ago • 1136 Views

Legal requirements for generics and abridged products and bioequivalence

16 years ago • 3186 Views

Significance of BA/BE studies in drug research and evaluation of different aspects

16 years ago • 7259 Views

The role of dissolution in the demonstration of bioequivalence

16 years ago • 12203 Views

Future trends and perspectives in modern pharmaceutical biotechnology

16 years ago • 8066 Views

Focussing on cytotoxic treatment alone is not enough

16 years ago • 1210 Views

Bioavailability and bioequivalence – problems and pitfalls

16 years ago • 9872 Views

Quo Vadis EU Pharmacy?

16 years ago • 1763 Views

Education - Do we have a choice?

16 years ago • 547 Views

The truth between the lines – Community pharmacists in improving the health of the public – The need for evidence based practice

16 years ago • 1437 Views

BY HELPING PEOPLE MY DREAM IS BECOMING TRUE

16 years ago • 727 Views

POSTGENETICS MEDICINE

16 years ago • 977 Views

SHARING VISION – TOWARDS BIOMEDICINE PARTNERS

16 years ago • 569 Views

Sightseeing Pharmacy practice - The way forward

16 years ago • 914 Views

EU telematics in the regulation of pharmaceuticals

16 years ago • 1334 Views

Generics and Biogenerics

16 years ago • 2615 Views

Pharmacovigilance Workshop

16 years ago • 9395 Views

ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG THERAPY?

16 years ago • 872 Views

Making knowledge matter: The Skills Inventory and the Competency Maps

16 years ago • 1559 Views

Trigger Point – Self-medication: Patients in white coats

16 years ago • 1170 Views